The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer

Clinicians have traditionally used clinicopathological (CP) factors to determine locoregional recurrence (LR) risk of breast cancer and have generated the IBTR! nomogram to predict the risk of ipsilateral breast tumor recurrence (IBTR). The 21-gene recurrence score (RS) assay was recently correlated...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Springerplus
Asıl Yazarlar: Thaker, Nikhil G, Hoffman, Karen E, Stauder, Michael C, Shaitelman, Simona F, Strom, Eric A, Tereffe, Welela, Smith, Benjamin D, Perkins, George H, Huo, Lei, Munsell, Mark F, Pusztai, Lajos, Buchholz, Thomas A, Woodward, Wendy A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2015
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318826/
https://ncbi.nlm.nih.gov/pubmed/25674496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-0840-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller